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used to supplement the information available from the medical records.
Results: 3 patients were pregnant (for the first time) at enrollment, 54 patients were
childless. 46 pregnancies, which resulted in live birth, were observed in the remaining 22
patients. In addition, 2 abortions (1 elective) were reported in the childless group and 10
(0 elective) in the patients with children. Mean age of the childless patients was 26 (SD
5,74), in patients with children 34 (SD 5,78) years. 5 patients reported fertility problems
and only 1 patient was advised against pregnancy by her cardiologist. Maternal compli-
cations were: arrhythmia (n=6) and heart failure (n=2), in 5 patients and in 6 pregnancies.
Caesarian section was performed 13 times (28%), of which 5 on maternal cardiac indica-
tion. Mean birth weight was 3064 g (SD 728). 5 births were premature (between 16 and
37 weeks) and 8 children (17%) were small for gestational age (<p10). 3 children died
within the first year of life. 2 children (4,3%) had congenital heart disease: 1 child had ToF
(died at 10 months), the other had several cardiac malformations in combination with tri-
somie 13.
Conclusion: In patients with ToF pregnancy is generally well tolerated. However, mater-
nal cardiac complications do occur in 13% of pregnancies. The need for Caesarian sec-
tion was increased. The incidence of small for gestational age children was increased.
Fertility seems not to be compromised.
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1114-198 Genomic Profiles of Left Ventricular and Right 
Ventricular Hypertrophy in Congenital Heart Disease
Beth D. Kaufman, Juan C. Osorio, Manisha Desai, Jonathan Chen, Ralph S. Mosca, Jan 
M. Quaegebeur, Anthony W. Ferrante, Seema Mital, Columbia University, College of 
Physicians & Surgeons, New York, NY
Background: Hemodynamic stimuli promote activation of gene expression pathways
that mediate ventricular hypertrophy. The LV has a greater ability to tolerate hemody-
namic load than the RV. Regulation of this differential response is not known.
Methods: Hypertrophied myocardium was obtained at surgery from 9 acyanotic pediatric
pts, 4 LVH and 5 RVH (age 0.15-6.7 yrs). Diagnoses included subaortic stenosis, subpul-
monary stenosis, and hypertrophic cardiomyopathy. Gene expression (GE) with Affyme-
trix DNA microarray gene chips was performed. After log transformation, differences in
mean GE between LVH and RVH groups with p value <0.01 was considered significant.
Genes with > 2-fold difference between the 2 groups were characterized and correlated
with severity of obstruction. Immunohistochemical staining was performed to detect myo-
cyte apoptosis with TUNEL assay, and fibrosis with trichrome stain in myocardium from
10pts with LVH and/or RVH.
Results: There were 253 genes with significant differences in expression between LVH
and RVH myocardium samples. 124 genes associated with myocardial hypertrophy,
cytoskeleton, apoptosis, and ion channels were upregulated in LVH. RVH group had 129
genes relatively overexpressed: extracellular matrix components, phospholipase A2 and
C, and mitochondrial transporter proteins. Fetal gene activation was present in both LVH
and RVH, with relative overexpression of cANF and dystrophin in the LV compared to RV
(p values <.01). Severity of obstructive gradients in both groups correlated positively with
actin and myosin GE, and negatively with apoptosis related genes (r = 0.8-0.9). ANP GE
correlated with LV obstruction only. Fibrosis and myocyte apoptosis was present in both
LVH and RVH specimens, but was greater in pts with HCM than those with isolated out-
flow tract lesions.
Conclusion: Myocardium from hypertrophied LV and RV has different genomic profiles.
Upregulation of genes in the LVH group that activate adaptive pathways may contribute
to the functional advantage observed in the LV vs. the RV with hemodynamic load, espe-
cially in pts with congenital heart disease. Further analysis of these candidate genes and
downstream signaling effects are warranted.
1114-199 A Comparison of Postnatal Changes in Fetal Phenotype 
Between the Left and Right Ventricles
Ana M. Duque Gonzalez, Juan C. Osorio, Susan Vannucci, Seema Mital, Columbia 
University, New York, NY
Background: The transition from fetal to neonatal circulation is characterized by an
increase in LV and decrease in RV size and thickness. This is associated with the disap-
pearance of fetal genes and expression of adult genes in the LV. The role of these adap-
tive genes in mediating RV remodeling has not been studied. The objective was to
determine the pattern of activation of fetal proteins in the left and right ventricles after
birth.
Methods: Hearts from 2 and 8 days old neonatal Sprague-Dawley rats (n=6 litters) were
isolated. In a novel approach, LV and RV were separated and expression of fetal proteins
was measured using Western blots - α -myosin heavy chain (MHC), α sarcomeric actin,
c-myc, c-jun (proto-oncogenes), atrial natriuretic peptide (ANP), and Glut 1 (glucose
transporter). The expression of upstream signaling proteins - protein kinase B (Akt), and
total and phosphorylated mitogen-activated protein kinases (MAPK – JNK, P38 MAPK,
p44/42) were also compared between LV and RV.
Results: At 2 days, the expression of α -MHC, ANP, Glut 1, ph-Akt, ph-JNK, and ph-p44/
42 were 20-70% lower in RV compared to LV (p<0.05). c-myc expression was not differ-
ent between LV and RV. ANP, c-myc, ph-JNK and ph-p44/42 increased in the LV at 8
days. In contrast, the RV showed a decrease in ANP and no change in c-myc despite an
increase in ph-JNK and ph-p44/42. Of the cytoskeletal fetal proteins, actin was higher in
the LV and α -MHC was higher in the RV at 8 days. Glut-1 was lower in RV at birth but
increased to levels seen in LV by 8 days.
Conclusions: Fetal proteins are down-regulated in the RV compared to the LV at birth,
including cytoskeletal, metabolic and immediate early genes. This may be related to
decreased activation of MAPKs and Akt in the RV and may account for decreased RV
growth post-natally. Whether the lower adaptibility of the RV compared to the LV to hemo-
dynamic load in disease is related to a reduced ability to activate or reactivate fetal genes
requires further study. To our knowledge, this is the first report comparing adaptive path-
ways between the LV and RV. Knowledge of these differences will be important in individ-
ualizing therapy to the pathways specific to each ventricle.
1114-200 Increased Incidence of Pulmonary Vein Stenosis in 
Patients With Atrioventricular Canal: A Multi-
Institutional Study
Henry W. Kort, Christine Hills, Virgil Larson, Mark C. Johnson, St. Louis Children's 
Hospital, St. Louis, MO, University of Minnesota, Minneapolis, MN
Background: Patients with atrioventricular canal (AVC) appear to be at greater risk for
the development of elevated pulmonary vascular resistance (PVR) than patients with
other cardiac defects. Review of our experience at a single institution suggested the inci-
dence of pulmonary vein stenosis (PVS) may be greater in a subgroup of patients with
AVC than in patients with other lesions. We set out to determine if this pattern held true in
a larger patient population.
Methods: The Pediatric Cardiac Care Consortium data base from 1981 to 2001
(n=90,879) was searched for all patients with a diagnosis of pulmonary vein obstruction
(PVS or cor triatriatum) and yielded 840 (0.9%) patients. Analysis by chi square was per-
formed on a subset of patients excluding those with a diagnosis of anomalous pulmonary
venous connections and a subset excluding those with a diagnosis of anomalous pulmo-
nary venous connections or cor triatriatum. The relationship of Trisomy 21 with pulmo-
nary vein obstruction was also investigated.
Results: After excluding cases with anomalous pulmonary venous connections, 509
(0.9%) patients were identified with pulmonary vein obstruction. In this group, 280 (0.3%)
patients were identified with PVS by excluding those with a diagnosis of cor triatriatum.
AVC was found with greater frequency in subsets of patients with pulmonary vein
obstruction, 13.7% (70 of 509, p<0.00001) and PVS, 12.5% (35 of 280, p=0.0028) as
compared with an 8.4% prevalence of AVC in patients without pulmonary vein obstruc-
tion (6,661 of 79,656, excluding anomalous pulmonary venous connections). There was
no association of Trisomy 21 with pulmonary vein obstruction (p=0.4).
Conclusion: Patients with AVC are at greater risk for concomitant pulmonary vein
obstruction and PVS than are patients with other congenital cardiac defects. Patients
with AVC and evidence of elevated PVR should undergo careful scrutiny of pulmonary
venous connections either by echocardiography or cardiac catheterization. Trisomy 21
does not appear to be associated with the increased incidence of pulmonary vein
obstruction.
1114-201 Higher Mortality After Fontan Surgery in Trisomy 21 
Syndrome Children
Monesha Gupta-Malhotra, Virgil E. V. Larson, Ronald M. Rosengart, James H. Moller, 
University of Minnesota, Minneapolis, MN
Background: High pulmonary artery pressure (PAP) is associated with increased mor-
tality after Fontan surgery. It is not known whether Trisomy 21 syndrome patients have a
higher PAP prior to Fontan when compared the to the non-Trisomy 21 patients.
Methods: We retrospectively evaluated data from our Pediatric Cardiac Care Consor-
tium (a data bank for all cardiac surgery cases from participating centers). Of the total
Fontan surgeries (n = 1966), 17 were performed on Trisomy 21 patients (Group II). Group
I were non-Trisomy patients after Fontan (n = 1949). Of Group II patients, 13 patients
(Group III) had had Fontan for unbalanced atrioventricular canal defects. Since it would
difficult to go through charts of such a large population, we selected a control group from
the Group I a total of 28 patients (Group IV) with atrioventricular canal defect who were
age (at Fontan) and sex matched and who were alive after the surgery. We evaluated the
pre-Fontan mean PAP in mmHg, pulmonary vascular resistance in woods units (PVR),
length of stay in days at hospital after surgery (LOS), weight in Kg at surgery (WT),
Hemoglobin prior to surgery in g/dL (Hb), whether there was prior Glenn surgery or not,
whether the Fontan was fenestrated (FEN) or not and whether there was preoperative
atrioventricular regurgitation (AVVR) or not.
Results: Between Groups I and II there was significantly higher mortality (p = 0.001)) in
Group II (n = 6/17, mean age at surgery 4.8 years) as compared to Group I (n = 204/
1949, mean age at surgery 6.6 years) without significant difference between the age, Hb,
WT and LOS. Between Group III (WT 16.2, Glenn 85%, AVVR 62%, FEN 54%, PAP 13.8,
PVR 2.9, Hb 15.9, LOS 21) and Group IV (WT 22, Glenn 61%, AVVR 57%, FEN 29%,
PAP 12.9, PVR 2.9, Hb 15.7, LOS 14) there were no significant differences in the param-
eters evaluated. Hence, in the selected population of Trisomy 21 who underwent Fontan
surgery, PAP and PVR were similar to the non-Trisomy 21 children.
Conclusion: The PAP is similar between Trisomy and non-Trisomy patients prior to Fon-
tan. Trisomy 21 syndrome is an independent parameter associated with significantly
higher risk of mortality (35%) after Fontan surgery as compared to non-Trisomy 21
patients (10%).
